Literature DB >> 377823

The contribution of gut-derived endotoxins to liver injury.

J P Nolan.   

Abstract

The liver serves as the key organ for the removal and detoxification of bacterial endotoxins that are continously absorbed in small amounts from the gastrointestinal tract. This paper postulates that liver injury impairs this detoxification process leading to further liver damage and systemic effects as well. Evidence is reviewed to support the contention that endotoxin may be a major common pathway for liver injury by a variety of agents, and methods of reducing endotoxicity of gut origin are proposed. Finally, a new solid phase radioimmunometric assay for E. coli 026 is described and its usefulness as a gut marker suggested.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377823      PMCID: PMC2595710     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  33 in total

1.  Experimental Shigella infections. III. Sensitivity of normal, starved and carbon tetrachloride treated guinea pigs to endotoxin.

Authors:  S B FORMAL; H E NOYES; H SCHNEIDER
Journal:  Proc Soc Exp Biol Med       Date:  1960-02

2.  Homologous and heterologous resistance in mice given bacterial endotoxins.

Authors:  R S ABERNATHY
Journal:  J Immunol       Date:  1957-05       Impact factor: 5.422

3.  Studies on the absorption of Escherichia coli endotoxin from the gastrointestinal tract of dogs in the pathogenesis of irreversible hemorrhagic shock.

Authors:  J P SANFORD; H E NOYES
Journal:  J Clin Invest       Date:  1958-10       Impact factor: 14.808

4.  Germfree animals and liver necrosis.

Authors:  T D LUCKEY; J A REYNIERS; P GYORGY; M FORBES
Journal:  Ann N Y Acad Sci       Date:  1954-05-10       Impact factor: 5.691

5.  Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin b--an antiendotoxin.

Authors:  J P Nolan; A I Leibowitz
Journal:  Gastroenterology       Date:  1978-09       Impact factor: 22.682

6.  Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.

Authors:  S C Bruins; R Stumacher; M A Johns; W R McCabe
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

7.  On the absorption of bacterial endotoxin from the gastro-intestinal tract of the normal and shocked animal.

Authors:  H A RAVIN; D ROWLEY; C JENKINS; J FINE
Journal:  J Exp Med       Date:  1960-11-01       Impact factor: 14.307

8.  The fever of Laennec's cirrhosis.

Authors:  W A TISDALE; G KLATSKIN
Journal:  Yale J Biol Med       Date:  1960-10

9.  The role of intestinal bacteria in the development of dietary cirrhosis in rats.

Authors:  A M RUTENBURG; E SONNENBLICK; I KOVEN; H A APRAHAMIAN; L REINER; J FINE
Journal:  J Exp Med       Date:  1957-07-01       Impact factor: 14.307

10.  INFLUENCE OF NEOMYCIN AND INGESTED ENDOTOXIN IN THE PATHOGENESIS OF CHOLINE DEFICIENCY CIRRHOSIS IN THE ADULT RAT.

Authors:  S A BROITMAN; L S GOTTLIEB; N ZAMCHECK
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.

Authors:  Julio Plaza-Diaz; Carolina Gomez-Llorente; Luis Fontana; Angel Gil
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 2.  Advances in alcoholic liver disease.

Authors:  Juliane I Beier; Gavin E Arteel; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2011-02

3.  Relationships between metabolic changes and clinical signs in pregnant sheep given endotoxin.

Authors:  J M Naylor; D S Kronfeld
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

4.  Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats.

Authors:  Julio Plaza-Diaz; Carolina Gomez-Llorente; Francisco Abadia-Molina; Maria Jose Saez-Lara; Laura Campaña-Martin; Sergio Muñoz-Quezada; Fernando Romero; Angel Gil; Luis Fontana
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

Review 5.  FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.

Authors:  Emma Henriksson; Birgitte Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-22       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.